---
$id: https://graph.org.ai/products/commodity/51272005
$type: Product
source: UNSPSC
code: "51272005"
title: "Methohexital sodium"
class: "51272000"
classTitle: "Anaesthetic barbiturates"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Methohexital sodium

**UNSPSC Code**: 51272005
**Class**: [Anaesthetic barbiturates](Anaesthetic barbiturates.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C14H17N2O3.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 60200PNZ7Q, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 1-methyl-5-(1-methyl-2-pentynyl)-5-(2-propenyl)-, (+-)-, monosodium salt but more generally known as methohexital sodium, which bears US NIH Compound Identifier 9391. European Medicines Agency schedules Methohexital sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03223MIG. Most nations, for tariff and trade purposes, schedule methohexital sodium under HS 29335400. As of Q4 2014, METHOHEXITAL SODIUM remains US FDA's Preferred Term for this commodity. Methohexital sodium bears US NLM identifiers UMLS ID C0304448 and NCI Concept Code C66117. SMILES: CCC#CC(C)C1(C(=O)[N-]C(=O)N(C1=O)C)CC=C.[NA+].

